Clinical Trial

A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China

Study acronym: CALM2001
Recruiting
View on ClinicalTrials.gov →
Summary
major objective This multicenter, prospective cohort study aims at evaluating the predictive value of microbiome ,proteomics and serum markers in preeclampsia. secondary objective to evaluate the value of microbiome,proteomics and serum markers in assessing pregnancy outcome (complications during pregnancy and delivery, delivery) and neonatal prognosis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-06-30.
Status change: Not Yet Recruiting → Recruiting 2023-02-03
Trial Details
NCT Number NCT05445544
Lead Sponsor Zhujiang Hospital
Collaborators: Nanfang Hospital, Southern Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Foshan Women's and Children's Hospital, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, First Affiliated Hospital of Wenzhou Medical University
Conditions Preeclampsia, Microbiome
Enrollment 10,000 participants
Start Date 2022-10-19
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-02-08